Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain

Dysregulation of ErbB-family signaling underlies numerous pathologies and has been therapeutically targeted through inhibiting ErbB-receptors themselves or their cognate ligands. For the latter, “decoy” antibodies have been developed to sequester ligands including heparin-binding epidermal growth fa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Miller, Miles A., Moss, Marcia L., Powell, Gary, Petrovich, Robert, Edwards, Lori, Meyer, Aaron S., Griffith, Linda G., Lauffenburger, Douglas A.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4609913/
https://ncbi.nlm.nih.gov/pubmed/26477568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep15150
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars